![David Philip Bloxham](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Philip Bloxham
Directeur Technique/Scientifique/R&D chez Celltech Group Ltd.
Profil
David Philip Bloxham is currently the Director of Research & Development at Celltech Group Ltd.
He previously held positions as Chairman at Evolutec Group Plc and The Babraham Institute, and as a Non-Executive Director at Cobra Biologics Holdings Ltd.
From 2011 to 2015, he served as an Independent Non-Executive Director at Ark Therapeutics Group Plc.
Bloxham earned a doctorate degree from The University of Southampton in 1971.
Postes actifs de David Philip Bloxham
Sociétés | Poste | Début |
---|---|---|
Celltech Group Ltd.
![]() Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de David Philip Bloxham
Sociétés | Poste | Fin |
---|---|---|
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 27/02/2015 |
Evolutec Group Plc
![]() Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Président | 04/05/2009 |
Cobra Biologics Holdings Ltd.
![]() Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Directeur/Membre du Conseil | 01/09/2006 |
The Babraham Institute
![]() The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Président | - |
Formation de David Philip Bloxham
The University of Southampton | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
Cobra Biologics Holdings Ltd.
![]() Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Health Technology |
Evolutec Group Plc
![]() Evolutec Group Plc BiotechnologyHealth Technology Evolutec Group Plc is an biopharmaceutical company, which discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. It was founded in1998 and headquartered in Oxford, United Kingdom. | Health Technology |
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
The Babraham Institute
![]() The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Commercial Services |
Celltech Group Ltd.
![]() Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Finance |